Ahabir (Abiraterone Acetate) is a medication used in the treatment of prostate cancer. It works by inhibiting the production of androgens, which can fuel the growth of cancer cells. This targeted therapy is often prescribed in conjunction with other treatments to enhance effectiveness.
Ahabir is indicated for use in patients with metastatic castration-resistant prostate cancer. It is typically prescribed for those whose cancer has progressed despite other forms of treatment.
The active ingredient, Abiraterone Acetate, blocks the enzyme CYP17, which is crucial for androgen production. By reducing androgen levels, Ahabir helps to slow down or halt the growth of prostate cancer cells.
The recommended dosage of Ahabir is typically taken once daily, and it is important to follow the prescribing physician's instructions. It is usually taken on an empty stomach to enhance absorption.
Common side effects may include fatigue, joint pain, and hypertension. More serious side effects can occur, and patients should be monitored for liver function and other potential complications.
Patients should inform their healthcare provider of any pre-existing conditions, particularly liver issues or heart problems. It is also important to discuss any other medications being taken to avoid interactions.
Q: Can Ahabir be taken with food?
A: Ahabir should be taken on an empty stomach for optimal absorption.
Q: How long will I need to take Ahabir?
A: The duration of treatment varies based on individual response and should be determined by your healthcare provider.
Q: Are there any alternatives to Ahabir?
A: There are other treatments available for prostate cancer. Discuss options with your healthcare provider.